UK Borrowing Reaches Highest Level Since Pandemic as Retail Sales Dip Amid Fuel Price Surge Amazon Allegedly Generated Millions Through NowIllegal Policy Reports Suggest Michael Burry Warns SECs Blockchain Trading Plan Could Create Nightmare for Investors Consumer Prices Rise 38 in April Marking Highest Annual Inflation Since May 2023 Plug Power Inc PLUG Ranks Among Most Traded US Stocks Amid Hydrogen Sector Momentum AI Boom Intensifies Optical Tech Supply Constraints as Huawei Stages Chip Comeback CPA Q1 2026 Earnings Strong EPS Surprise Despite Flat Stock Reaction Murphy USA MUSA Q1 2026 Earnings Strong EPS Beat of 415 Drives Investor Focus on Operational Efficiency LTRN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Control as RD Pipeline Advances ESTA Q1 2026 Earnings WiderthanExpected Loss Reflects RD and Commercial Investments Worthington Enterprises WOR Q1 2026 Earnings EPS Slightly Beats Estimates as Stock Gains 11 LRN Q1 2026 Earnings EPS Beat Drives Positive Momentum Despite Revenue Uncertainty RF Acquisition Corp III RFAM Holds Steady at 988 Amid Low Volatility ZIONP Holds Steady at 1925 Preferred Stock Offers Stability Amid Narrow Trading Range TIM SA TIMB Edges Lower as Telecom Sector Faces ProfitTaking Hologic Inc Holds Steady at 7601 as Traders Assess Support and Resistance Levels Align Technology ALGN Maintains Slight Advance as Shares Approach Key Resistance Level Versus Systems Inc VS Q4 2025 Earnings Narrowing Loss Supports Stock Rally Marine Products Corporation MPX Q1 2026 Earnings Weak Profitability and Stock Decline Highlight Ongoing Challenges NJR Q1 2026 Earnings EPS Surges Past Estimates with 14 Surprise VAC Q1 2026 Earnings EPS Misses Estimates by 255 Yet Shares Gain 609 ACB Q1 2026 Earnings EPS Miss Tempers Optimism After Return to Profitability AGNCN Q1 2026 Earnings EPS Surpasses Estimates by 145 Morning Squawk Micron Milestone Dicks Earnings Paxton Defeats Cornyn Lead Investor Agenda SPB Q1 2026 Earnings Earnings Beat Estimates Amidst Solid Operational Execution Nurix Therapeutics NRIX Rallies 230 as Buyers Test Resistance Near 1867